Publications

• Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective.
  Aliment Pharmacol Ther Volume: 61 Page(s): 1467 - 1478
  05/01/2025 Authors: Younossi ZM; Razavi H; Sherman M; Allen AM; Anstee QM; Cusi K; Friedman SL; Lawitz E; Lazarus JV; Schuppan D
• Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers.
  Vaccines (Basel) Volume: 13
  02/07/2025 Authors: Hatabah D; Gupta SL; Mantus G; Sullivan P; Heilman S; Camacho-Gonzalez A; Leake D; Le M; Griffiths M; Norwood C
• Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes.
  Hepatology
  01/03/2025 Authors: Newton KP; Jayasekera D; Blackford AL; Behling C; Wilson LA; Fishbein MH; Molleston JP; Xanthakos SA; Vos MB; Schwimmer JB
• Corrigendum to "Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study" [Internation Journal of Infectious Diseases, volume 144 (2024) 107064].
  Int J Infect Dis Volume: 149 Page(s): 107278
  12/01/2024 Authors: Griffiths M; Hatabah D; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Heilman S; Camacho-Gonzalez A; Leake D; Korman R
• Fasting intact insulin by mass spectrometry is associated with metabolic dysfunction-associated steatotic liver disease in youth.
  Hepatol Commun Volume: 8
  12/01/2024 Authors: Huneault HE; Lo JS; Bai S; He Z; McPhaul MJ; Bril F; Vos MB; Cree MG
• Pediatric MASLD: current understanding and practical approach.
  Eur J Pediatr Volume: 184 Page(s): 29
  11/19/2024 Authors: Stroes A-SR; Vos M; Benninga MA; Koot BGP
• Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis.
  J Pediatr Gastroenterol Nutr Volume: 79 Page(s): 943 - 953
  11/01/2024 Authors: Jain AK; Busgang SA; Gennings C; Yates KP; Schwimmer JB; Rosenthal P; Murray KF; Molleston JP; Scheimann A; Xanthakos SA
• Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort.
  Hepatol Commun Volume: 8
  11/01/2024 Authors: Sanchez-Torres C; Ramirez Tovar A; Chatman K; Morris HL; Yu F; Mospan AR; Diehl AM; Leung DH; Viswanathan P; Squires JE
• Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity.
  J Pediatr Gastroenterol Nutr Volume: 79 Page(s): 238 - 249
  08/01/2024 Authors: Mouzaki M; Yates KP; Arce-Clachar AC; Behling C; Blondet NM; Fishbein MH; Flores F; Adams KH; Hertel P; Jain AK
• Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study.
  Int J Infect Dis Volume: 144 Page(s): 107064
  07/01/2024 Authors: Griffiths M; Hatabah D; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Heilman S; Camacho-Gonzalez A; Leake D; Korman R
• Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
  Volume: 79 Page(s): 1381 - 1392
  06/01/2024 Authors: Wang A; Blackford AL; Behling C; Wilson LA; Newton KP; Xanthakos SA; Fishbein MH; Vos MB; Mouzaki M; Molleston JP
• Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD.
  Clin Gastroenterol Hepatol Volume: 22 Page(s): 1024 - 1036.e2
  05/01/2024 Authors: Jarasvaraparn C; Vilar-Gomez E; Yates KP; Wilson LA; Neuschwander-Tetri B; Loomba R; Cummings O; Vos M; Xanthakos S; Schwimmer J
• Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease.
  Metabolites Volume: 14
  03/28/2024 Authors: Huneault HE; Chen C-Y; Cohen CC; Liu X; Jarrell ZR; He Z; DeSantos KE; Welsh JA; Maner-Smith KM; Ortlund EA
• Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics.
  Hepatol Commun Volume: 8
  03/01/2024 Authors: Huneault HE; Gent AE; Cohen CC; He Z; Jarrell ZR; Kamaleswaran R; Vos MB
• Glucagon-like Peptide-1 Receptor Agonists-A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD).
  Children (Basel) Volume: 11
  02/23/2024 Authors: Choi E; Ramirez Tovar A; He Z; Soler Rodriguez DM; Vos MB; Arora S; Fadoju D
• Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease.
  Child Obes Volume: 20 Page(s): 41 - 47
  01/01/2024 Authors: Kraus EM; Pierce SL; Porter R; Kompaniyets L; Vos MB; Blanck HM; King RJ; Goodman AB
• A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
  Ann Hepatol Volume: 29 Page(s): 101133
  01/01/2024 Authors: Rinella ME; Lazarus JV; Ratziu V; Francque SM; Sanyal AJ; Kanwal F; Romero D; Abdelmalek MF; Anstee QM; Arab JP
• A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
  Hepatology Volume: 78 Page(s): 1966 - 1986
  12/01/2023 Authors: Rinella ME; Lazarus JV; Ratziu V; Francque SM; Sanyal AJ; Kanwal F; Romero D; Abdelmalek MF; Anstee QM; Arab JP
• A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
  J Hepatol Volume: 79 Page(s): 1542 - 1556
  12/01/2023 Authors: Rinella ME; Lazarus JV; Ratziu V; Francque SM; Sanyal AJ; Kanwal F; Romero D; Abdelmalek MF; Anstee QM; Arab JP
• Nutrition assessment and MASH severity in children using the Healthy Eating Index.
  Hepatol Commun Volume: 7
  12/01/2023 Authors: Jain AK; Buchannan P; Yates KP; Belt P; Schwimmer JB; Rosenthal P; Murray KF; Molleston JP; Scheimann A; Xanthakos SA
• The Impact and Burden of Dietary Sugars on the Liver.
  Hepatol Commun Volume: 7
  11/01/2023 Authors: Huneault HE; Ramirez Tovar A; Sanchez-Torres C; Welsh JA; Vos MB
• Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.
  Clin Gastroenterol Hepatol Volume: 21 Page(s): 2889 - 2900.e10
  10/01/2023 Authors: Sanyal AJ; Munoz B; Cusi K; Barritt AS; Muthiah M; Mospan AR; Reddy KR; Firpi-Morell R; Thuluvath PJ; Bhamidimarri KR
• Study protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent nonalcoholic fatty liver disease in Hispanic children.
  Contemp Clin Trials Volume: 129 Page(s): 107170
  06/01/2023 Authors: Welsh JA; Pyo E; Huneault H; Gonzalez Ramirez L; Alazraki A; Alli R; Dunbar SB; Khanna G; Knight-Scott J; Pimentel A
• Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
  Clin Gastroenterol Hepatol Volume: 21 Page(s): 1261 - 1270
  05/01/2023 Authors: Newton KP; Wilson LA; Crimmins NA; Fishbein MH; Molleston JP; Xanthakos SA; Behling C; Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network
• Special Population: Pediatric Nonalcoholic Fatty Liver Disease.
  Clin Liver Dis Volume: 27 Page(s): 471 - 482
  05/01/2023 Authors: Dybbro E; Vos MB; Kohli R
• Metabolome Microbiome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys.
  Metabolites Volume: 13
  03/08/2023 Authors: Cohen CC; Huneault H; Accardi CJ; Jones DP; Liu K; Maner-Smith KM; Song M; Welsh JA; Ugalde-Nicalo PA; Schwimmer JB
• Untargeted, High-Resolution Metabolomics in Pediatric Eosinophilic Esophagitis.
  J Pediatr Gastroenterol Nutr Volume: 76 Page(s): 355 - 363
  03/01/2023 Authors: Sinclair EM; Cohen CC; Tran V; Jones DP; Alvarez JA; Kamaleswaran R; Rad MG; Kruszewski PG; Vos MB
• Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.
  Hepatology Volume: 77 Page(s): 530 - 545
  02/01/2023 Authors: Leung DH; Devaraj S; Goodrich NP; Chen X; Rajapakshe D; Ye W; Andreev V; Minard CG; Guffey D; Molleston JP
• Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children.
  Hepatology Volume: 77 Page(s): 197 - 212
  01/01/2023 Authors: Goyal NP; Rosenthal SB; Nasamran C; Behling CA; Angeles JE; Fishbein MH; Harlow KE; Jain AK; Molleston JP; Newton KP
• Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis.
  Front Nutr Volume: 10 Page(s): 1158452
  01/01/2023 Authors: Daley TC; Cousineau BA; Nesbeth P-DC; Ivie EA; Bellissimo MP; Easley KA; Vellanki P; Vos MB; Hunt WR; Stecenko AA
• Metabolomics profiling in acute liver transplant rejection in a pediatric population.
  Sci Rep Volume: 12 Page(s): 18663
  11/04/2022 Authors: Frediani JK; Beyh YS; Gupta N; Westbrook AL; Cleeton R; Cordero M; Hernandez A; Tran V; Jones DP; Vos MB
• Renal impairment in children with nonalcoholic fatty liver disease
  Volume: 76 Page(s): S678 - S679
  10/01/2022 Authors: Mouzaki M; Yates K; Behling C; Blondet N; Fishbein MH; Harlow KE; Jain AK; Newton KP; Schwimmer JB; Vos MB
• NUTRITION ADEQUACY AND NASH SEVERITY IN CHILDREN USING THE HEALTHY EATING INDEX
  Volume: 76 Page(s): S1525 - S1526
  10/01/2022 Authors: Jain AK; Buchanan P; Yates K; Schwimmer JB; Rosenthal P; Murray KF; Molleston JP; Scheimann A; Xanthakos SA; Behling C
• Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant.
  Clin Infect Dis Volume: 75 Page(s): 1131 - 1139
  09/30/2022 Authors: Westbrook AL; Benedit LC; Frediani JK; Griffiths MA; Khan NY; Levy JM; Morris CR; Rostad CA; Stone CL; Sullivan J
• Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
  JAMA Volume: 328 Page(s): 935 - 940
  09/13/2022 Authors: Waggoner JJ; Vos MB; Tyburski EA; Nguyen P-V; Ingersoll JM; Miller C; Sullivan J; Griffiths M; Stone C; Benoit M
• Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia.
  Hepatology Volume: 76 Page(s): 712 - 726
  09/01/2022 Authors: Bass LM; Ye W; Hawthorne K; Leung DH; Murray KF; Molleston JP; Romero R; Karpen S; Rosenthal P; Loomes KM
• Comparison of Mid-turbinate Nasal Swabs, Saliva, and Nasopharyngeal Swabs for SARS-CoV-2 Reverse Transcription-Polymerase Chain Reaction Testing in Pediatric Outpatients.
  Arch Pathol Lab Med Volume: 146 Page(s): 1056 - 1061
  09/01/2022 Authors: Vos MB; Gonzalez MD; Stone C; Cleeton R; Figueroa J; Jerris R; Park SI; Heilman S; Nayee R; Chahroudi A
• Randomized placebo-controlled trial of losartan for pediatric NAFLD.
  Hepatology Volume: 76 Page(s): 429 - 444
  08/01/2022 Authors: Vos MB; Van Natta ML; Blondet NM; Dasarathy S; Fishbein M; Hertel P; Jain AK; Karpen SJ; Lavine JE; Mohammad S
• The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
  BMC Gastroenterol Volume: 22 Page(s): 366
  07/30/2022 Authors: Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P
• Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children.
  JAMA Netw Open Volume: 5 Page(s): e2220176
  07/01/2022 Authors: Midya V; Colicino E; Conti DV; Berhane K; Garcia E; Stratakis N; Andrusaityte S; Basagaa X; Casas M; Fossati S
• American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
  Endocr Pract Volume: 28 Page(s): 528 - 562
  05/01/2022 Authors: Cusi K; Isaacs S; Barb D; Basu R; Caprio S; Garvey WT; Kashyap S; Mechanick JI; Mouzaki M; Nadolsky K
• Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.
  Children (Basel) Volume: 9
  03/08/2022 Authors: Castillo-Leon E; Morris HL; Schoen C; Bilhartz J; McKiernan P; Miloh T; Palle S; Kabbany MN; Munoz B; Mospan AR
• Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
  J Clin Invest Volume: 131
  12/15/2021 Authors: Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ
• Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).
  Exp Biol Med (Maywood) Volume: 246 Page(s): 2543 - 2552
  12/01/2021 Authors: Kuypers FA; Rostad CA; Anderson EJ; Chahroudi A; Jaggi P; Wrammert J; Mantus G; Basu R; Harris F; Hanberry B
• Microbial metabolite delta-valerobetaine is a diet-dependent obesogen.
  Nat Metab Volume: 3 Page(s): 1694 - 1705
  12/01/2021 Authors: Liu KH; Owens JA; Saeedi B; Cohen CE; Bellissimo MP; Naudin C; Darby T; Druzak S; Maner-Smith K; Orr M
• Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
  Aliment Pharmacol Ther Volume: 54 Page(s): 1472 - 1480
  12/01/2021 Authors: Kim HP; Idowu MO; Mospan AR; Allmon AG; Roden M; Newsome P; Lok AS; Thuluvath PJ; Taunk J; Fried MW
• PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD.
  Hepatol Commun Volume: 5 Page(s): 1860 - 1872
  11/01/2021 Authors: Cohen CC; Castillo-Leon E; Farris AB; Caltharp SA; Cleeton RL; Sinclair EM; Shevell DE; Karsdal MA; Nielsen MJF; Leeming DJ
• Correlation of SARS-CoV-2 Subgenomic RNA with Antigen Detection in Nasal Midturbinate Swab Specimens.
  Emerg Infect Dis Volume: 27 Page(s): 2887 - 2891
  11/01/2021 Authors: Immergluck K; Gonzalez MD; Frediani JK; Levy JM; Figueroa J; Wood A; Rogers BB; O'Neal J; Elias-Marcellin R; Suessmith A
• THE PREVALENCE OF ALCOHOLIC AND NONALCOHOLIC FATTY LIVER DISEASE IN ADOLESCENTS AND YOUNG ADULTS IN THE UNITED STATES: ANALYSIS OF THE NHANES DATABASE
  Volume: 74 Page(s): 31A - 32A
  10/01/2021 Authors: Alkhouri N; Le P; Yang J; Sakkal C; Polanco P; Vos MB; Noureddin M
• MULTI-LAYER MOLECULAR SIGNATURES OF LIVER INJURY IN EUROPEAN CHILDREN
  Volume: 74 Page(s): 1171A - 1171A
  10/01/2021 Authors: Stratakis N; Goodrich J; Dominic D; Bustamante M; Valvi D; Garcia E; Maitre L; Heude B; Grazuleviciene R; Vafeiadi M
• In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood.
  Hepatology Volume: 74 Page(s): 1546 - 1559
  09/01/2021 Authors: Stratakis N; Golden-Mason L; Margetaki K; Zhao Y; Valvi D; Garcia E; Maitre L; Andrusaityte S; Basagana X; Borrs E
• The need for new test verification and regulatory support for innovative diagnostics.
  Nat Biotechnol Volume: 39 Page(s): 1060 - 1062
  09/01/2021 Authors: Roback JD; Tyburski EA; Alter D; Asakrah S; Chahroudi A; Esper A; Farmer S; Figueroa J; K Frediani J; D Gonzalez M
• Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24years.
  Pediatr Obes Volume: 16 Page(s): e12773
  08/01/2021 Authors: Cohen CC; Sekkarie A; Figueroa J; Gillespie SE; Vos MB; Welsh JA
• Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2.
  Sci Rep Volume: 11 Page(s): 14903
  07/21/2021 Authors: Levy JM; Frediani JK; Tyburski EA; Wood A; Figueroa J; Kempker RR; Rebolledo PA; Gonzalez MD; Sullivan J; Vos MB
• Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration.
  Sci Rep Volume: 11 Page(s): 14604
  07/16/2021 Authors: Frediani JK; Levy JM; Rao A; Bassit L; Figueroa J; Vos MB; Wood A; Jerris R; Van Leung-Pineda; Gonzalez MD
• Associations of maternal diet and nutritional status with offspring hepatic steatosis in the Avon longitudinal study of parents and children.
  BMC Nutr Volume: 7 Page(s): 28
  07/08/2021 Authors: Sekkarie A; Welsh JA; Northstone K; Stein AD; Ramakrishnan U; Vos MB
• Altered amino acid profile in patients with SARS-CoV-2 infection.
  Proc Natl Acad Sci U S A Volume: 118
  06/22/2021 Authors: Rees CA; Rostad CA; Mantus G; Anderson EJ; Chahroudi A; Jaggi P; Wrammert J; Ochoa JB; Ochoa A; Basu RK
• Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study.
  Hepatol Commun Volume: 5 Page(s): 938 - 946
  06/01/2021 Authors: Barritt AS; Watkins S; Gitlin N; Klein S; Lok AS; Loomba R; Schoen C; Reddy KR; Trinh HN; Mospan AR
• Prenatal and childhood exposure to air pollution and traffic and the risk of liver injury in European children.
  Environ Epidemiol Volume: 5 Page(s): e153
  06/01/2021 Authors: Garcia E; Stratakis N; Valvi D; Maitre L; Varo N; Aasvang GM; Andrusaityte S; Basagana X; Casas M; de Castro M
• Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis.
  Liver Int Volume: 41 Page(s): 996 - 1011
  05/01/2021 Authors: Allende DS; Gawrieh S; Cummings OW; Belt P; Wilson L; Van Natta M; Behling CA; Carpenter D; Gill RM; Kleiner DE
• The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.
  IEEE Open J Eng Med Biol Volume: 2 Page(s): 142 - 151
  04/28/2021 Authors: Nehl E; Heilman S; Ku D; Gottfried D; Farmer S; Mannino R; Tyburski E; Sullivan J; Suessmith A; Bassit L
• Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort.
  Children (Basel) Volume: 8
  04/08/2021 Authors: Sekkarie A; Welsh JA; Northstone K; Stein AD; Ramakrishnan U; Vos MB
• Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
  Int J Infect Dis Volume: 105 Page(s): 474 - 481
  04/01/2021 Authors: Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J
• Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis.
  Hepatology Volume: 73 Page(s): 937 - 951
  03/01/2021 Authors: Newton KP; Lavine JE; Wilson L; Behling C; Vos MB; Molleston JP; Rosenthal P; Miloh T; Fishbein MH; Jain AK
• Covid-19 will not "magically disappear": Why access to widespread testing is paramount.
  Am J Hematol Volume: 96 Page(s): 174 - 178
  02/01/2021 Authors: George PE; Stokes CL; Bassit LC; Chahroudi A; Figueroa J; Griffiths MA; Heilman S; Ku DN; Nehl EJ; Leong T
• The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.
  IEEE Open J Eng Med Biol Volume: 2 Page(s): 152 - 157
  01/01/2021 Authors: Gibson L; Fahey N; Hafer N; Buchholz B; Dunlap D; Murphy R; Achenbach C; Stone C; Cleeton R; O'Neal J
• Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension.
  J Pediatr Volume: 227 Page(s): 81 - 86.e4
  12/01/2020 Authors: Teckman J; Rosenthal P; Hawthorne K; Spino C; Bass LM; Murray KF; Kerkar N; Magee JC; Karpen S; Heubi JE
• Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
  Gastroenterology Volume: 159 Page(s): 1731 - 1751.e10
  11/01/2020 Authors: Xanthakos SA; Lavine JE; Yates KP; Schwimmer JB; Molleston JP; Rosenthal P; Murray KF; Vos MB; Jain AK; Scheimann AO
• Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children.
  Hepatology Volume: 72 Page(s): 1758 - 1770
  11/01/2020 Authors: Stratakis N; V Conti D; Jin R; Margetaki K; Valvi D; Siskos AP; Maitre L; Garcia E; Varo N; Zhao Y
• ANALYSIS OF PRO-C3, A BIOMARKER OF LIVER FIBROSIS, IN CHILDREN WITH NAFLD AND HEALTHY CONTROLS
  Volume: 72 Page(s): 873A - 873A
  11/01/2020 Authors: Castillo-Leon E; Cioffi C; Cleeton RL; Farris AB; Leeming DJ; Shevell D; Nielsen MJ; Vos MB
• PRENATAL EXPOSURE TO MERCURY TRIGGERS INFLAMMATION AND INCREASES THE RISK OF LIVER INJURY IN CHILDHOOD
  Volume: 72 Page(s): 986 - 987
  11/01/2020 Authors: Stratakis N; Golden-Mason L; Margetaki K; Conti D; Valvi D; Zhao Y; Garcia E; Maitre L; Heude B; Grazuleviciene R
• Deep-learning-based accurate hepatic steatosis quantification for histological assessment of liver biopsies.
  Lab Invest Volume: 100 Page(s): 1367 - 1383
  10/01/2020 Authors: Roy M; Wang F; Vo H; Teng D; Teodoro G; Farris AB; Castillo-Leon E; Vos MB; Kong J
• Perspectives on youth-onset nonalcoholic fatty liver disease.
  Endocrinol Diabetes Metab Volume: 3 Page(s): e00184
  10/01/2020 Authors: Castillo-Leon E; Cioffi CE; Vos MB
• Prevalence of SARS-CoV-2 Antibodies in Pediatric Health Care Workers in Atlanta, Georgia
  Volume: 76 Page(s): S124 - S125
  10/01/2020 Authors: Morris CR; Camacho-Gonzalez A; Chen C; Heilman S; Iyer S; Mantus G; Sanchez T; Sullivan P; Suthar M; Wrammert J
• Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis.
  Pediatr Obes Volume: 15 Page(s): e12648
  09/01/2020 Authors: Castillo-Leon E; Connelly MA; Konomi JV; Caltharp S; Cleeton R; Vos MB
• ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.
  Children (Basel) Volume: 7
  09/01/2020 Authors: Sekkarie A; Welsh JA; Northstone K; Cioffi CE; Stein AD; Figueroa J; Ramakrishnan U; Vos MB
• Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth.
  BMJ Open Diabetes Res Care Volume: 8
  07/01/2020 Authors: Cioffi CE; Narayan KMV; Liu K; Uppal K; Jones DP; Tran V; Yu T; Alvarez JA; Bellissimo MP; Maner-Smith KM
• Understanding childhood obesity in the US: the NIH environmental influences on child health outcomes (ECHO) program.
  Int J Obes (Lond) Volume: 44 Page(s): 617 - 627
  03/01/2020 Authors: Tylavsky FA; Ferrara A; Catellier DJ; Oken E; Li X; Law A; Dabelea D; Rundle A; Gilbert-Diamond D; Hivert M-F
• Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.
  Environ Int Volume: 134 Page(s): 105220
  01/01/2020 Authors: Jin R; McConnell R; Catherine C; Xu S; Walker DI; Stratakis N; Jones DP; Miller GW; Peng C; Conti DV
• Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life.
  Ann Hepatol Volume: 19 Page(s): 373 - 379
  01/01/2020 Authors: Sekkarie A; He S; Welsh JA; Ramakrishnan U; Stein AD; Vos MB
• Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.
  Gastroenterology Volume: 157 Page(s): 1448 - 1456.e1
  12/01/2019 Authors: Vos MB; Dimick-Santos L; Mehta R; Omokaro SO; Taminiau J; Schabel E; Kleiner DE; Szitanyi P; Socha P; Schwimmer JB
• Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study.
  J Gen Intern Med Volume: 34 Page(s): 2772 - 2778
  12/01/2019 Authors: Cleveland ER; Ning H; Vos MB; Lewis CE; Rinella ME; Carr JJ; Lloyd-Jones DM; VanWagner LB
• Associations of Added Sugar from All Sources and Sugar-Sweetened Beverages with Regional Fat Deposition in US Adolescents: NHANES 1999-2006.
  Curr Dev Nutr Volume: 3 Page(s): nzz130
  12/01/2019 Authors: Cioffi CE; Welsh JA; Alvarez JA; Hartman TJ; Narayan KMV; Vos MB
• Plasma High-Resolution Metabolomics Differentiates Adults with Normal Weight Obesity from Lean Individuals.
  Obesity (Silver Spring) Volume: 27 Page(s): 1729 - 1737
  11/01/2019 Authors: Bellissimo MP; Cai Q; Ziegler TR; Liu KH; Tran PH; Vos MB; Martin GS; Jones DP; Yu T; Alvarez JA
• Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics.
  Hepatol Commun Volume: 3 Page(s): 1311 - 1321
  10/01/2019 Authors: Khusial RD; Cioffi CE; Caltharp SA; Krasinskas AM; Alazraki A; Knight-Scott J; Cleeton R; Castillo-Leon E; Jones DP; Pierpont B
• PATIENT REPORTED OUTCOMES AMONG PEDIATRIC PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: TARGET-NASH
  Volume: 70 Page(s): 752A - 753A
  10/01/2019 Authors: Rudolph B; Bilhartz J; Schoen C; Selvakumar PKC; Palle SK; Xanthakos S; McKiernan PJ; Mavis A; Barritt AS; Vos MB
• PATTERNS OF MEDICATION USE AMONG ADULT PATIENTS WITH ELEVATED SERUM ALT LEVELS IN PATIENTS WITH NAFLD: TARGET-NASH
  Volume: 70 Page(s): 734A - 734A
  10/01/2019 Authors: Barritt AS; Watkins S; Neuschwander-Tetri BA; Schoen C; Desai R; Vos MB; Malahias L; Malespin MH; Newsome PN; Reddy KR
• Truncal-to-leg fat ratio and cardiometabolic disease risk factors in US adolescents: NHANES 2003-2006.
  Pediatr Obes Volume: 14 Page(s): e12509
  07/01/2019 Authors: Cioffi CE; Alvarez JA; Welsh JA; Vos MB
• Low Free Sugar Diet in Adolescents With Nonalcoholic Fatty Liver Disease-Reply.
  JAMA Volume: 321 Page(s): 2469
  06/25/2019 Authors: Schwimmer JB; Ugalde-Nicalo P; Vos MB
• Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
  Hepatology Volume: 69 Page(s): 2672 - 2682
  06/01/2019 Authors: Younossi Z; Tacke F; Arrese M; Chander Sharma B; Mostafa I; Bugianesi E; Wai-Sun Wong V; Yilmaz Y; George J; Fan J
• Clustering of Metabolomics, Clinical Biomarkers, and Ectopic Liver Fat in Children/Adolescents: An Integrated Network Analysis
  Volume: 68
  06/01/2019 Authors: Cioffi CE; Narayan KMV; Uppal K; Pierpont B; Caprio S; Santoro N; Vos MB
• Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
  JAMA Volume: 321 Page(s): 256 - 265
  01/22/2019 Authors: Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP
• Advances in Pediatric Fatty Liver Disease: Pathogenesis, Diagnosis, and Treatment.
  Gastroenterol Clin North Am Volume: 47 Page(s): 949 - 968
  12/01/2018 Authors: Braun HA; Faasse SA; Vos MB
• Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD.
  Nutrients Volume: 10
  11/21/2018 Authors: Song M; Vos MB; McClain CJ
• Twenty-five-year trajectories of insulin resistance and pancreatic -cell response and diabetes risk in nonalcoholic fatty liver disease.
  Liver Int Volume: 38 Page(s): 2069 - 2081
  11/01/2018 Authors: VanWagner LB; Ning H; Allen NB; Siddique J; Carson AP; Bancks MP; Lewis CE; Carr JJ; Speliotes E; Terrault NA
• Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
  Hepatol Commun Volume: 2 Page(s): 1369 - 1378
  11/01/2018 Authors: Deneau MR; Mack C; Abdou R; Amin M; Amir A; Auth M; Bazerbachi F; Marie Broderick A; Chan A; DiGuglielmo M
• Clinical Outcomes of Oral Vancomycin Therapy for Children with Primary Sclerosing Cholangitis in the Pediatric PSC Consortium
  Volume: 68 Page(s): 114A - 115A
  10/01/2018 Authors: Deneau M; Abdou R; Amin M; Amir AZ; Auth M; Broderick A; Chan A; DiGuglielmo M; El-Matary W; El-Youssef M
• Sedentary Behaviors in Today's Youth: Approaches to the Prevention and Management of Childhood Obesity: A Scientific Statement From the American Heart Association.
  Circulation Volume: 138 Page(s): e142 - e159
  09/11/2018 Authors: Barnett TA; Kelly AS; Young DR; Perry CK; Pratt CA; Edwards NM; Rao G; Vos MB; American Heart Association Obesity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; and Stroke Council
• Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease.
  J Pediatr Volume: 198 Page(s): 76 - 83.e2
  07/01/2018 Authors: Harlow KE; Africa JA; Wells A; Belt PH; Behling CA; Jain AK; Molleston JP; Newton KP; Rosenthal P; Vos MB
• Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents.
  Curr Opin Clin Nutr Metab Care Volume: 21 Page(s): 283 - 288
  07/01/2018 Authors: Sekkarie A; Welsh JA; Vos MB
• Segmentation of Overlapped Steatosis in Whole-Slide Liver Histopathology Microscopy Images.
  Annu Int Conf IEEE Eng Med Biol Soc Volume: 2018 Page(s): 810 - 813
  07/01/2018 Authors: Roy M; Wang F; Teodoro G; Vos MB; Farris AB; Kong J
• Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data.
  Children (Basel) Volume: 5
  05/25/2018 Authors: Arsik I; Frediani JK; Frezza D; Chen W; Ayer T; Keskinocak P; Jin R; Konomi JV; Barlow SE; Xanthakos SA
• Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
  Liver Int Volume: 38 Page(s): 706 - 714
  04/01/2018 Authors: VanWagner LB; Khan SS; Ning H; Siddique J; Lewis CE; Carr JJ; Vos MB; Speliotes E; Terrault NA; Rinella ME
• Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas.
  Mol Genet Metab Volume: 123 Page(s): 428 - 432
  04/01/2018 Authors: Li H; Byers HM; Diaz-Kuan A; Vos MB; Hall PL; Tortorelli S; Singh R; Wallenstein MB; Allain M; Dimmock DP
• In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
  Clin Gastroenterol Hepatol Volume: 16 Page(s): 438 - 446.e1
  03/01/2018 Authors: Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE
• Performance of fibrosis prediction scores in paediatric non-alcoholic fatty liver disease.
  J Paediatr Child Health Volume: 54 Page(s): 172 - 176
  02/01/2018 Authors: Jackson JA; Konomi JV; Mendoza MV; Krasinskas A; Jin R; Caltharp S; Mouzaki M; Vos MB
• Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
  Environ Health Volume: 17 Page(s): 6
  01/15/2018 Authors: Frediani JK; Naioti EA; Vos MB; Figueroa J; Marsit CJ; Welsh JA
• Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.
  Pediatr Obes Volume: 13 Page(s): 23 - 29
  01/01/2018 Authors: Jin R; Krasinskas A; Le N-A; Konomi JV; Holzberg J; Romero R; Vos MB
• Dietary copper-fructose interactions alter gut microbial activity in male rats.
  Am J Physiol Gastrointest Liver Physiol Volume: 314 Page(s): G119 - G130
  01/01/2018 Authors: Song M; Li X; Zhang X; Shi H; Vos MB; Wei X; Wang Y; Gao H; Rouchka EC; Yin X
• The role of NAFLD in cardiometabolic disease: an update.
  F1000Res Volume: 7 Page(s): 170
  01/01/2018 Authors: Faasse S; Braun H; Vos M
• A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease.
  Pilot Feasibility Stud Volume: 4 Page(s): 109
  01/01/2018 Authors: Vos MB; Jin R; Konomi JV; Cleeton R; Cruz J; Karpen S; Rodriguez DS; Frediani JK; McCracken C; Welsh J
• Response to the Letters Regarding the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition NAFLD Guidelines.
  J Pediatr Gastroenterol Nutr Volume: 65 Page(s): e115 - e116
  11/01/2017 Authors: Vos MB; Abrams SH; Barlow SE; Caprio S; Daniels SR; Kohli R; Mouzaki M; Sathya P; Schwimmer JB; Sundaram SS
• Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.
  Contemp Clin Trials Volume: 61 Page(s): 33 - 38
  10/01/2017 Authors: Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K
• Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross-sectional, single-center study in the USA.
  Pediatr Transplant Volume: 21
  09/01/2017 Authors: He S; Le NA; Frediani JK; Winterberg PD; Jin R; Liverman R; Hernandez A; Cleeton RL; Vos MB
• Sugar, Sugar . . . Not So Sweet for the Liver.
  Gastroenterology Volume: 153 Page(s): 642 - 645
  09/01/2017 Authors: Vos MB; Goran MI
• Response to Letters Regarding the NASPGHAN NAFLD Guidelines.
  J Pediatr Gastroenterol Nutr
  09/01/2017 Authors: Vos MB; Abrams SH; Barlow SE; Caprio S; Daniels SR; Kohli R; Mouzaki M; Sathya P; Schwimmer JB; Sundaram SS
• The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
  Hepatology Volume: 66 Page(s): 518 - 527
  08/01/2017 Authors: Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A
• Low Hepatic Tissue Copper in Pediatric Nonalcoholic Fatty Liver Disease.
  J Pediatr Gastroenterol Nutr Volume: 65 Page(s): 89 - 92
  07/01/2017 Authors: Mendoza M; Caltharp S; Song M; Collin L; Konomi JV; McClain CJ; Vos MB
• Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
  Circulation Volume: 135 Page(s): e1017 - e1034
  05/09/2017 Authors: Vos MB; Kaar JL; Welsh JA; Van Horn LV; Feig DI; Anderson CAM; Patel MJ; Cruz Munos J; Krebs NF; Xanthakos SA
• Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study.
  Children (Basel) Volume: 4
  05/03/2017 Authors: Cioffi CE; Welsh JA; Cleeton RL; Caltharp SA; Romero R; Wulkan ML; Konomi JV; Frediani JK; Vos MB
• Low Hepatic Tissue Copper in Pediatric Non-Alcoholic Fatty Liver Disease.
  J Pediatr Gastroenterol Nutr
  03/17/2017 Authors: Mendoza M; Caltharp S; Song M; Collin L; Konomi JV; McClain CJ; Vos MB
• NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).
  J Pediatr Gastroenterol Nutr Volume: 64 Page(s): 319 - 334
  02/01/2017 Authors: Vos MB; Abrams SH; Barlow SE; Caprio S; Daniels SR; Kohli R; Mouzaki M; Sathya P; Schwimmer JB; Sundaram SS
• In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.
  Gastroenterology Volume: 151 Page(s): 1141 - 1154.e9
  12/01/2016 Authors: Schwimmer JB; Lavine JE; Wilson LA; Neuschwander-Tetri BA; Xanthakos SA; Kohli R; Barlow SE; Vos MB; Karpen SJ; Molleston JP
• NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children.
  J Pediatr Gastroenterol Nutr
  11/30/2016 Authors: Vos MB; Abrams SH; Barlow SE; Caprio S; Daniels SR; Kohli R; Mouzaki M; Sathya P; Schwimmer JB; Sundaram SS
• Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association.
  Circulation Volume: 134 Page(s): e505 - e529
  11/29/2016 Authors: Van Horn L; Carson JAS; Appel LJ; Burke LE; Economos C; Karmally W; Lancaster K; Lichtenstein AH; Johnson RK; Thomas RJ
• Addition of Portal Inflammation to the NAFLD Activity Score Improves Utility for Pediatric NAFLD
  Volume: 64 Page(s): 275A - 275A
  10/01/2016 Authors: Vos MB; Jin R; Alkhouri N; Konomi J; Mendoza M; Krasinskas A; Caltharp S
• Standardized Time Average of ALT is a Better Marker of Histologic Improvement in NAFLD
  Volume: 64 Page(s): 559A - 560A
  10/01/2016 Authors: Frezza D; Chen W; Keskinocak P; Ayer T; Jin R; Barlow SE; Xanthakos S; Lavine JE; Vos MB
• Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.
  J Pediatr Gastroenterol Nutr Volume: 62 Page(s): 819 - 823
  06/01/2016 Authors: Holzberg JR; Jin R; Le N-A; Ziegler TR; Brunt EM; McClain CJ; Konomi JV; Arteel GE; Vos MB
• Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study.
  J Pediatr Volume: 172 Page(s): 14 - 19.e5
  05/01/2016 Authors: Jin R; Banton S; Tran VT; Konomi JV; Li S; Jones DP; Vos MB
• Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee onNonalcoholic Fatty LiverDisease (ECON).
  J Pediatr Volume: 172 Page(s): 9 - 13
  05/01/2016 Authors: Kohli R; Sunduram S; Mouzaki M; Ali S; Sathya P; Abrams S; Xanthakos SA; Vos M; Schwimmer JB
• Cysteamine Bitartrate Delayed-Release (DR) for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh) Trial
  HEPATOLOGY Volume: 62 Page(s): 1398A - 1399A
  12/01/2015 Authors: Schwimmer JB; Lavine JE; Neuschwander-Tetri BA; Wilson L; Xanthakos SA; Barlow SE; Vos MB; Molleston JP; Whitington PF; Rosenthal P
• Discovery of plasma biomarkers for NAFLD using high resolution metabolomics
  Volume: 62 Page(s): 1295A - 1295A
  10/01/2015 Authors: Vos MB; Jin R; Banton S; Li S; Jones DP
• Fructose and liver function--is this behind nonalcoholic liver disease?
  Curr Opin Clin Nutr Metab Care Volume: 18 Page(s): 490 - 495
  09/01/2015 Authors: Jin R; Vos MB
• Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?
  Hepatology Volume: 61 Page(s): 1779 - 1780
  06/01/2015 Authors: Vos MB
• Brief training in patient-centered counseling for healthy weight management increases counseling self-efficacy and goal setting among pediatric primary care providers: results of a pilot program.
  Clin Pediatr (Phila) Volume: 54 Page(s): 425 - 429
  05/01/2015 Authors: Welsh JA; Nelson JM; Walsh S; Sealer H; Palmer W; Vos MB
• Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.
  Lipids Health Dis Volume: 14 Page(s): 39
  05/01/2015 Authors: Jin R; Le N-A; Cleeton R; Sun X; Cruz Muos J; Otvos J; Vos MB
• Weight management-related assessment and counseling by primary care providers in an area of high childhood obesity prevalence: current practices and areas of opportunity.
  Child Obes Volume: 11 Page(s): 194 - 201
  04/01/2015 Authors: Nelson JM; Vos MB; Walsh SM; O'Brien LA; Welsh JA
• Replacement of Sugar-Sweetened Beverages with Water and its Impact on Insulin Sensitivity Among Overweight Adolescents and Young Adults
  Volume: 29
  04/01/2015 Authors: Jin R; Collin L; Vos M; Welsh J
• Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.
  J Pediatr Gastroenterol Nutr Volume: 60 Page(s): 360 - 367
  03/01/2015 Authors: Corey KE; Vuppalanchi R; Vos M; Kohli R; Molleston JP; Wilson L; Unalp-Arida A; Cummings OW; Lavine JE; Chalasani N
• Challenges and successes of a multidisciplinary pediatric obesity treatment program.
  Nutr Clin Pract Volume: 29 Page(s): 780 - 785
  12/01/2014 Authors: Walsh SM; Palmer W; Welsh JA; Vos MB
• Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.
  Nutrients Volume: 6 Page(s): 3187 - 3201
  08/08/2014 Authors: Jin R; Welsh JA; Le N-A; Holzberg J; Sharma P; Martin DR; Vos MB
• Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin.
  Clin Gastroenterol Hepatol Volume: 12 Page(s): 1170 - 1178
  07/01/2014 Authors: Siddique A; Nelson JE; Aouizerat B; Yeh MM; Kowdley KV; NASH Clinical Research Network
• Consumption of less than 10% of total energy from added sugars is associated with increasing HDL in females during adolescence: a longitudinal analysis.
  J Am Heart Assoc Volume: 3 Page(s): e000615
  02/26/2014 Authors: Lee AK; Binongo JNG; Chowdhury R; Stein AD; Gazmararian JA; Vos MB; Welsh JA
• Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.
  Curr Opin Lipidol Volume: 25 Page(s): 61 - 66
  02/01/2014 Authors: Vos MB
• Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
  J Pediatr Gastroenterol Nutr Volume: 58 Page(s): 74 - 80
  01/01/2014 Authors: Whitington PF; Vos MB; Bass LM; Melin-Aldana H; Romero R; Roy CC; Alvarez F
• Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease.
  Int J Hepatol Volume: 2014 Page(s): 560620
  01/01/2014 Authors: Jin R; Willment A; Patel SS; Sun X; Song M; Mannery YO; Kosters A; McClain CJ; Vos MB
• Extremely low awareness and under-diagnosis of NAFLD in a population-based sample
  Volume: 60 Page(s): 619A - 619A
  01/01/2014 Authors: VanWagner LB; Rinella ME; Ning H; Lloyd-Jones DM; Lewis CE; Vos MB
• Modest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats.
  Obesity (Silver Spring) Volume: 21 Page(s): 1669 - 1675
  08/01/2013 Authors: Song M; Schuschke DA; Zhou Z; Chen T; Shi X; Zhang J; Zhang X; Pierce WM; Johnson WT; Vos MB
• Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure.
  J Pediatr Volume: 163 Page(s): 201 - 206
  07/01/2013 Authors: Bulut OP; Romero R; Mahle WT; McConnell M; Braithwaite K; Shehata BM; Gupta NA; Vos M; Alazraki A
• Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease.
  Hepatology Volume: 58 Page(s): 4 - 5
  07/01/2013 Authors: Vos MB
• Liver steatosis assessment: correlations among pathology, radiology, clinical data and automated image analysis software.
  Pathol Res Pract Volume: 209 Page(s): 371 - 379
  06/01/2013 Authors: Lee MJ; Bagci P; Kong J; Vos MB; Sharma P; Kalb B; Saltz JH; Martin DR; Adsay NV; Farris AB
• Dietary fructose in nonalcoholic fatty liver disease.
  Hepatology Volume: 57 Page(s): 2525 - 2531
  06/01/2013 Authors: Vos MB; Lavine JE
• Fructose reduction improves CVD risk in adolescents with NAFLD
  Volume: 27
  04/01/2013 Authors: Vos M; Jin R; Welsh J; Ngoc-Anh L
• Acute lipids response to fructose beverage in adolescents with NAFLD
  Volume: 27
  04/01/2013 Authors: Jin R; Ngoc-Anh L; Vos M
• Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.
  J Pediatr Volume: 162 Page(s): 496 - 500.e1
  03/01/2013 Authors: Welsh JA; Karpen S; Vos MB
• Assessment of nutrition education among pediatric gastroenterologists: a survey of NASPGHAN members.
  J Pediatr Gastroenterol Nutr Volume: 56 Page(s): 137 - 144
  02/01/2013 Authors: Lin HC; Kahana D; Vos MB; Black D; Port Z; Shulman R; Scheimann A; Mascarenhas MR
• Youth understanding of healthy eating and obesity: a focus group study.
  J Obes Volume: 2013 Page(s): 670295
  01/01/2013 Authors: Sylvetsky AC; Hennink M; Comeau D; Welsh JA; Hardy T; Matzigkeit L; Swan DW; Walsh SM; Vos MB
• Hepatic fat predicts increased inflammation in obese Hispanic children
  Volume: 56 Page(s): 910A - 910A
  10/01/2012 Authors: Mannery Y; McClain CJ; Vos MB
• Contrasting Mechanisms of Liver Injury in Two Childhood Autoimmune Diseases
  Volume: 56 Page(s): 726A - 726A
  10/01/2012 Authors: Vos MB; Whitington PF; Bass LM; Alonso EM; Melin-Aldana H; Romero R; Roy C; Alvarez F
• Low-calorie sweetener consumption is increasing in the United States.
  Volume: 96 Page(s): 640 - 646
  09/01/2012 Authors: Sylvetsky AC; Welsh JA; Brown RJ; Vos MB
• Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD.
  J Clin Endocrinol Metab Volume: 97 Page(s): E1088 - E1098
  07/01/2012 Authors: Jin R; Le N-A; Liu S; Farkas Epperson M; Ziegler TR; Welsh JA; Jones DP; McClain CJ; Vos MB
• MRI Identifies Unsuspected Liver Dysfunction in Patients After Fontan Procedure
  Volume: 142 Page(s): S925 - S926
  05/01/2012 Authors: Bulut P; Romero R; McConnell M; Braithwaite K; Mahle W; Gupta NA; Vos MB; Alazraki A
• Prevalence of Suspected NAFLD is Increasing Among US Adolescents
  Volume: 142 Page(s): S925 - S925
  05/01/2012 Authors: Vos MB; Welsh J
• The association between sugar intake and HDL levels varies by sugar type and source
  Volume: 26
  04/01/2012 Authors: Welsh JA; Vos MB
• Liver Steatosis Assessment: Correlations among Pathology, Radiology, Clinical Data and Automated Image Analysis Software
  Volume: 92 Page(s): 417A - 418A
  02/01/2012 Authors: Lee M; Bagci P; Kong J; Vos M; Adsay V; Sharma P; Martin D; Farris A
• Liver Steatosis Assessment: Correlations among Pathology, Radiology, Clinical Data and Automated Image Analysis Software
  Volume: 25 Page(s): 417A - 418A
  02/01/2012 Authors: Lee M; Bagci P; Kong J; Vos M; Adsay V; Sharma P; Martin D; Farris A
• Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure.
  Pediatr Crit Care Med Volume: 13 Page(s): e33 - e38
  01/01/2012 Authors: Kamat P; Kunde S; Vos M; Vats A; Gupta N; Heffron T; Romero R; Fortenberry JD
• Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.
  J Pediatr Gastroenterol Nutr Volume: 54 Page(s): 90 - 96
  01/01/2012 Authors: Vos MB; Colvin R; Belt P; Molleston JP; Murray KF; Rosenthal P; Schwimmer JB; Tonascia J; Unalp A; Lavine JE
• Update in childhood and adolescent obesity.
  Pediatr Clin North Am Volume: 58 Page(s): xv - xvii
  12/01/2011 Authors: Vos M; Barlow SE
• Hepatic oxidative stress in fructose-induced fatty liver is not caused by sulfur amino acid insufficiency.
  Nutrients Volume: 3 Page(s): 987 - 1002
  11/01/2011 Authors: Kunde SS; Roede JR; Vos MB; Orr ML; Go Y-M; Park Y; Ziegler TR; Jones DP
• Keratin 18, Apoptosis, and Liver Disease in Children.
  Curr Pediatr Rev Volume: 7 Page(s): 310 - 315
  11/01/2011 Authors: Mannery YO; McClain CJ; Vos MB
• Parental Attitudes Toward Healthy Eating and Exercise in Georgia
  Volume: 19 Page(s): S215 - S216
  11/01/2011 Authors: Sylvetsky AC; Welsh JA; Swan DW; Ridley K; Vos M
• PAI-1 PREDICTS HEPATIC STEATOSIS AND MARKERS OF CELL DEATH IN NAFLD
  Volume: 54 Page(s): 1124A - 1124A
  10/01/2011 Authors: Vos MB; Mannery Y; Falkner KC; Gupta NA; Romero R; Martin DR; Brunt EM; McClain CJ
• Consumption of added sugars is decreasing in the United States.
  Am J Clin Nutr Volume: 94 Page(s): 726 - 734
  09/01/2011 Authors: Welsh JA; Sharma AJ; Grellinger L; Vos MB
• Pediatric liver transplantation for primary sclerosing cholangitis.
  Liver Transpl Volume: 17 Page(s): 925 - 933
  08/01/2011 Authors: Miloh T; Anand R; Yin W; Vos M; Kerkar N; Alonso E; Studies of Pediatric Liver Transplantation Research Group
• Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents.
  Circulation Volume: 123 Page(s): 249 - 257
  01/25/2011 Authors: Welsh JA; Sharma A; Cunningham SA; Vos MB
• Childhood obesity: update on predisposing factors and prevention strategies.
  Curr Gastroenterol Rep Volume: 12 Page(s): 280 - 287
  08/01/2010 Authors: Vos MB; Welsh J
• New safety data on the high-protein-low-carbohydrate diet in adolescents.
  J Pediatr Volume: 157 Page(s): 184 - 185
  08/01/2010 Authors: Vos M
• Caloric sweetener consumption and dyslipidemia among US adults.
  JAMA Volume: 303 Page(s): 1490 - 1497
  04/21/2010 Authors: Welsh JA; Sharma A; Abramson JL; Vaccarino V; Gillespie C; Vos MB
• Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.
  Eur J Gastroenterol Hepatol Volume: 22 Page(s): 494 - 499
  04/01/2010 Authors: Verhelst X; Orlent H; Colle I; Geerts A; De Vos M; Van Vlierberghe H
• Pediatric liver transplantation for acute liver failure at a single center: a 10-yr experience.
  Pediatr Transplant Volume: 14 Page(s): 228 - 232
  03/01/2010 Authors: Heffron TG; Pillen T; Smallwood G; Rodriguez J; Sekar S; Henry S; Vos M; Casper K; Gupta NA; Fasola CG
• Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system.
  Expert Rev Gastroenterol Hepatol Volume: 4 Page(s): 81 - 89
  02/01/2010 Authors: De Vos M
• Nonalcoholic fatty liver disease: pathology and pathogenesis.
  Annu Rev Pathol Volume: 5 Page(s): 145 - 171
  01/01/2010 Authors: Tiniakos DG; Vos MB; Brunt EM
• Fructose takes a toll.
  Hepatology Volume: 50 Page(s): 1004 - 1006
  10/01/2009 Authors: Vos MB; McClain CJ
• PEDIATRIC LIVER TRANSPLANTATION FOR SCLEROSING CHOLANGITIS (PSC)
  Volume: 50 Page(s): 753A - 754A
  10/01/2009 Authors: Miloh TA; Anand R; Yin W; Vos MB; Kerkar N; Alonso E
• INCREASED POSTPRANDIAL PLASMA TRIGLYCERIDES IN RESPONSE TO FRUCTOSE IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
  Volume: 50 Page(s): 802A - 802A
  10/01/2009 Authors: Vos M; Le N-A; Martin DR; Sharma P; McClain CJ; Jones D
• Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique.
  Radiology Volume: 252 Page(s): 568 - 576
  08/01/2009 Authors: Pineda N; Sharma P; Xu Q; Hu X; Vos M; Martin DR
• Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study.
  Arch Pediatr Adolesc Med Volume: 163 Page(s): 674 - 675
  07/01/2009 Authors: Vos MB; Weber MB; Welsh J; Khatoon F; Jones DP; Whitington PF; McClain CJ
• Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction.
  J Magn Reson Imaging Volume: 29 Page(s): 629 - 635
  03/01/2009 Authors: Sharma P; Martin DR; Pineda N; Xu Q; Vos M; Anania F; Hu X
• Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.
  J Pediatr Gastroenterol Nutr Volume: 47 Page(s): 481 - 485
  10/01/2008 Authors: Vos MB; Barve S; Joshi-Barve S; Carew JD; Whitington PF; McClain CJ
• Nutrition and nonalcoholic fatty liver disease in children.
  Curr Diab Rep Volume: 8 Page(s): 399 - 406
  10/01/2008 Authors: Vos MB; McClain CJ
• HIGH-SPEED (T2)-CORRECTED MULTI-ECHO (HISTO) MAGNETIC RESONANCE SPECTROSCOPY: A FAST, REPRODUCIBLE, NON-INVASIVE TECHNIQUE FOR ACCURATE HEPATIC LIND QUANTIFICATION
  Volume: 48 Page(s): 995A - 995A
  10/01/2008 Authors: Sharma P; Alonso NP; Xu Q; Vos MB; Martin DR
• FRUCTOSE IS ASSOCIATED WITH INCREASED OXIDATIVE STRESS AND ELEVATED PLASMA TRIGLYCERIDES IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
  Volume: 48 Page(s): 820A - 820A
  10/01/2008 Authors: Vos M; McClain CJ; Jones D
• Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.
  Medscape J Med Volume: 10 Page(s): 160
  07/09/2008 Authors: Vos MB; Kimmons JE; Gillespie C; Welsh J; Blanck HM
• Nutrition and nonalcoholic fatty liver disease in children.
  Curr Gastroenterol Rep Volume: 10 Page(s): 308 - 315
  06/01/2008 Authors: Vos MB; McClain CJ
• Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.
  J Hepatol Volume: 48 Page(s): 983 - 992
  06/01/2008 Authors: Bergheim I; Weber S; Vos M; Krmer S; Volynets V; Kaserouni S; McClain CJ; Bischoff SC
• Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice.
  Hepatol Res Volume: 38 Page(s): 1130 - 1139
  01/01/2008 Authors: Geerts AM; Vanheule E; Van Vlierberghe H; Leybaert L; Van Steenkiste C; De Vos M; Colle I
• Effect of sugar-sweetened beverages on hepatic steatosis in mice
  Volume: 44 Page(s): 213A - 214A
  10/01/2006 Authors: Kaserouni S; Vos MV; Mueller-Blech K; McClain CJ; Bischoff SC; Bergheim I
• Low adiponectin is associated with increased cell death in pediatric nonalcoholic fatty liver disease
  Volume: 44 Page(s): 648A - 648A
  10/01/2006 Authors: Vos MB; Barve S; Joshi-Barve S; Redinger D; Sullivan J; Whitington P; McClain CJ
• Follow-up of overweight children and adolescents diagnosed at well-child visits.
  Volume: 54 Page(s): S282 - S282
  01/01/2006 Authors: Jeffries AP; Louthan MV; Franco SM; Valdes XL; Theriot JA
• Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease.
  J Pediatr Volume: 147 Page(s): 835 - 838
  12/01/2005 Authors: Louthan MV; Barve S; McClain CJ; Joshi-Barve S
• Decreased prevalence of nonalcoholic fatty liver disease in black obese children.
  J Pediatr Gastroenterol Nutr Volume: 41 Page(s): 426 - 429
  10/01/2005 Authors: Louthan MV; Theriot JA; Zimmerman E; Stutts JT; McClain CJ
• Racial differences in adiponectin in overweight children
  Volume: 128 Page(s): A695 - A695
  04/01/2005 Authors: Louthan M; Sullivan J; Joshi-Barve S; McClain C
• Racial effects of adiponectin in overweight children.
  Volume: 53 Page(s): S391 - S391
  03/01/2005 Authors: Louthan MV; Sullivan J; Joshi-Barve S; McClain C
• Diagnosis and treatment frequency for overweight children and adolescents at well child visits.
  Clin Pediatr (Phila) Volume: 44 Page(s): 57 - 61
  01/01/2005 Authors: Louthan MV; Lafferty-Oza MJ; Smith ER; Hornung CA; Franco S; Theriot JA
• Child lifestyle choices and obesity.
  JOURNAL OF INVESTIGATIVE MEDICINE Volume: 53 Page(s): S258 - S258
  01/01/2005 Authors: Sayat JG; Louthan MV; Franco SM; Theriot JA
• Maternal perception of their child's weight is a barrier to early diagnosis and treatment
  JOURNAL OF INVESTIGATIVE MEDICINE Volume: 53 Page(s): S297 - S297
  01/01/2005 Authors: Sayat JG; Louthan MV; Franco SM; Theriot JA
• Decreased serum adiponectin levels in children with NAFLD.
  Volume: 40 Page(s): 591A - 591A
  10/01/2004 Authors: Louthan M; Joshi-Barve S; Hill D; McClain C
• Decreased serum adiponectin levels in children with NAFLD
  Volume: 12 Page(s): A124 - A124
  10/01/2004 Authors: Louthan M; Sullivan J; McClain C
• Body mass index utilization improves the diagnosis of overweight children
  Volume: 55 Page(s): 219A - 219A
  04/01/2004 Authors: Louthan MV; Forbes D; Smith ER; Franco SM; Theriot JA
• Body mass index utilization in the diagnosis of overweight pediatric population.
  Volume: 52 Page(s): S286 - S286
  01/01/2004 Authors: Louthan MV; Forbes D; Smith ER; Franco SM; Theriot JA
• Diagnosis and treatment rates for overweight children and adolescents at well child visits
  Volume: 53 Page(s): 246A - 246A
  04/01/2003 Authors: Louthan MV; Lafferty-Oza MJ; Smith ER; Hornung CA; Theriot JA
• Diagnosis and treatment rates for overweight children and adolescents at well child visits.
  Volume: 51 Page(s): S373 - S374
  03/01/2003 Authors: Louthan MV; Lafferty-Oza MJ; Smith ER; Hornung CA; Theriot JA
• Effect of parental weight on the risk of being overweight in preadolescents.
  Volume: 51 Page(s): S284 - S284
  02/01/2003 Authors: Louthan MV; Klein LR; Looney SW; Hagan JL; Jones VF
• Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
  Viral Immunol Volume: 13 Page(s): 329 - 341
  01/01/2000 Authors: Marshall GS; Li M; Stout GG; Louthan MV; Dulige AM; Burke RL; Hunt LA
• Congenital hepatic fibrosis.
  J Hepatol Volume: 6 Page(s): 222 - 228
  04/01/1988 Authors: De Vos M; Barbier F; Cuvelier C